Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2012

Conditions
Type 2 Diabetes MellitusPancreatic Beta Cell FunctionGlucotoxicity
Interventions
DRUG

intensive insulin group

Once daily long acting insulin and preprandial rapid acting insulin injection

DRUG

Oral AntiDiabetic Drug (glimepiride and metformin)

glimepiride and metformin combined therapy

Trial Locations (8)

471-020

Hanyang University Medical Center, Guri-si

Unknown

The Catholic University of Korea Bucheon St.Mary's Hospital, Bucheon-si

Jeju National University Hospital, Jeju-do

Kyung Hee University East Weast Neo Medicalcenter, Seoul

400-711

Inha University Hospital, Incheon

130-702

Kyunghee University Medical Center, Seoul

152-730

Korea University Guro Hospital, Seoul

443-721

Ajou University Medical Center, Suwon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Korea University Guro Hospital

OTHER

collaborator

Hanyang University

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Ajou University

OTHER

collaborator

Sanofi

INDUSTRY

collaborator

East West Neo Medical Center

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Jeju National University Hospital

OTHER

lead

Kyunghee University Medical Center

OTHER